Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Etanercept Appears Effective, Well Tolerated for Giant Cell Arteritis
Link ID 6159
Title Etanercept Appears Effective, Well Tolerated for Giant Cell Arteritis
Url http://www.medscape.com/viewarticle/575219?src=rss
Description Etanercept may potentially replace corticosteroid therapy for patients with giant cell arteritis (GCA) who are experiencing adverse effects from the corticosteroid, according to the first randomized, double-blind, placebo-controlled trial of etanercept in patients with GCA. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date May 29, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Orlistat, Sibutramine, Rimonabant Reduce Weight and Have Specific Adverse Effects
  A meta-analysis of randomized trials shows modest weight reduction for orlistat, sibutramine, and rimonabant, with differing effects on cardiovascular risk profiles and specific adverse effects. Medscape Medical News
Category:   Articles > Pharmacists


2. Profound Hypocitraturia Follows Topiramate Therapy
  Topiramate therapy can induce profound declines in urinary citrate levels, which may lead to urinary stones, according to a report in the July issue of Urology. Reuters Health Information
Category:   Articles > Pharmacists


3. Biomarkers May Help Identify Patients at Risk for Inflammatory Arthritis
  Serum cytokine profiles may be useful in guiding treatment decisions and prognosis. Medscape Medical News
Category:   Articles > Pharmacists


4. Inhaled Dihydroergotamine Mesylate Well-Tolerated, Achieves High Blood Levels
  Pulmonary absorption of inhaled dihydroergotamine (DHE) mesylate, intended for treatment of acute migraine, produces plasma levels comparable to intravenous administration in healthy individuals, and is well-tolerated, investigators report in the March issue of Headache. Reuters Health Information
Category:   Articles > Pharmacists


5. Pfizer Wins Ruling That May Limit Celebrex Suits
  Pfizer Inc has won a U.S. court ruling that could limit the lawsuits claiming that its Celebrex painkiller caused heart attacks and strokes. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS